Earnings History Data for AbCellera Biologics Inc. (ABCL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AbCellera Biologics Inc.

AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-08-2021	AH	4:05 PM ET (Aug 12)	ABCL	AbCellera Biologics Inc.	4,220	-0.01	0.09	0.00	AbCellera Biologics EPS misses by $0.09, misses on revenue [8/12/2021 4:20 PM]	17.86	2.67 (17.58%)	15.06	-0.13 (-0.86%)	14.51 - 71.91	9,783,072	1,400,000	30,203
AbCellera Biologics EPS misses by $0.09, misses on revenue [8/12/2021 4:20 PM] AbCellera rises over 15% most since March despite revenue miss [8/13/2021 11:31 AM] AbCellera Reports Q2 2021 Business Results [Aug-12-21 04:05PM] AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript [Aug-13-21 12:30AM] Why AbCellera Biologics Stock Was Up More Than 17% on Friday [Aug-13-21 12:52PM]
13-05-2021	AH	After the close (May 13)	ABCL	AbCellera Biologics Inc.	7,650	0.37	0.37	0.00	AbCellera Biologics EPS misses by $0.01, beats on revenue [5/13/2021 4:34 PM]	31.72	-2.42 (-7.09%)	31.60	-2.54 (-7.44%)	23.20 - 71.91	798,614	1,020,000	7,004
AbCellera Biologics EPS misses by $0.01, beats on revenue [5/13/2021 4:34 PM] AbCellera Reports Q1 2021 Business Results [May-13-21 04:05PM] AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript [May-13-21 11:30PM] Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug [May-14-21 11:51AM]
29-03-2021	AH	After the close (Mar 29)	ABCL	AbCellera Biologics Inc.	7,160	N/A	2.11	0.00	AbCellera Biologics EPS misses by $0.14, beats on revenue [3/29/2021 4:17 PM]	26.70	3.41 (14.64%)	26.92	3.63 (15.59%)	23.20 - 71.91	2,789,256	1,000,000	71,729
AbCellera Biologics EPS misses by $0.14, beats on revenue [3/29/2021 4:17 PM] AbCellera Biologics climbs as partnership business boosts 2020 revenue [3/29/2021 6:07 PM] AbCellera Reports Full Year 2020 Business Results [Mar-29-21 04:05PM]